|
Re: a new study that one researcher called "stunning."
|
9
|
Resverlogix Corp.
|
Feb 10, 2022 07:39PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
6
|
Zenith Epigenetics
|
Feb 09, 2022 01:51PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
4
|
Zenith Epigenetics
|
Feb 08, 2022 02:47PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
5
|
Zenith Epigenetics
|
Jan 31, 2022 11:03AM
|
|
Video
|
8
|
Resverlogix Corp.
|
Jan 29, 2022 03:09PM
|
|
Re: Don On 630 CHED's Afternoon Show
|
5
|
Resverlogix Corp.
|
Jan 20, 2022 05:23PM
|
|
Re: Good news thoughts
|
10
|
Resverlogix Corp.
|
Jan 18, 2022 06:46PM
|
|
Re: Study Start Date now 1-14-22
|
11
|
Resverlogix Corp.
|
Jan 12, 2022 11:53AM
|
|
Re: Trial Inclusion criteria #6
|
11
|
Resverlogix Corp.
|
Jan 12, 2022 11:16AM
|
|
Long term risks associated with covid
|
10
|
Resverlogix Corp.
|
Jan 05, 2022 10:04PM
|
|
Re: possible catalyst(s)??
|
7
|
Zenith Epigenetics
|
Dec 21, 2021 06:12PM
|
|
Re: So…..let’s see what kind of information we get
|
3
|
BIOASIS TECHNOLOGIES INC
|
Dec 17, 2021 02:37PM
|
|
Re: Update
|
8
|
Resverlogix Corp.
|
Dec 17, 2021 02:16PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
7
|
Resverlogix Corp.
|
Dec 15, 2021 05:25PM
|
|
Re: Corporate Update Webcast and Conference Call December 16, 2021 @ 2 PM MST
|
9
|
Resverlogix Corp.
|
Dec 15, 2021 02:05PM
|
|
Re: Response from Sarah -were still a go
|
11
|
Resverlogix Corp.
|
Dec 03, 2021 12:22PM
|
|
Re: Response from Sarah -were still a go
|
6
|
Resverlogix Corp.
|
Dec 02, 2021 07:52PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
7
|
Resverlogix Corp.
|
Nov 30, 2021 05:10PM
|
|
Regarding mice and Covid
|
6
|
Resverlogix Corp.
|
Nov 30, 2021 05:06PM
|
|
Re: New Variant
|
7
|
Resverlogix Corp.
|
Nov 26, 2021 01:58PM
|
